Gavi Board Approves Next Five Year Strategy; Outlines Plans to Support Access to New Vaccines, Global Health Security, and Sustainability

Published on June 20, 2024

The Gavi Board has approved its 2030 strategy, focusing on new vaccine introductions, especially for malaria and other priority diseases. Key decisions include enhancing vaccine sovereignty for countries, supporting sustainable immunization programs, and addressing gaps in vaccine coverage. The strategy emphasizes equitable access to vaccines, innovation, and collaboration with partners to strengthen health systems globally. For more details, click the link below!

Read the 2030 Strategy!

Other news

Gavi Announces Launch of Multiple Vaccines

June 20, 2024
Gavi has announced the launch of several new preventive vaccination programs. These programs include vaccines for Ebola, multivalent meningitis, human rabies, and hepatitis B. The initiative aims to enhance routine immunization and ensure broader protection against these diseases. This effort is part of Gavi's ongoing mission to strengthen health systems and improve access to essential vaccines in

WHO: Shipment of Newest Malaria Vaccine to Central African Repubic

June 20, 2024
The World Health Organization announced the shipment of the newest malaria vaccine, R21, to the Central African Republic. This milestone aims to enhance child survival rates by addressing malaria, a major cause of child mortality in the region. The R21 vaccine promises to be a crucial tool in reducing the burden of malaria and improving public health outcomes. For more details, click the link belo